GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK
GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK in February 2014. The ...
GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK in February 2014. The ...
Ireland’s Government is to invest €5m over the next five years in a new Pharmaceutical Manufacturing Technology Centre (PMTC) that ...
Cambridge, UK-based biopharma company Ario Pharma says it has acquired the TRPA1 antagonist research program previously owned by privately-held Italian ...
In the second quarter of 2003 the Swedish vaccine producer, SBL Vaccin AB, brought on-line a major extension and upgrade ...
Polpharma began production at its new Dry Forms II plant (Oddzial Formy Suche II – FSII Solid Forms Branch) in ...
GSK Biologicals, the vaccine division of the pharmaceutical and healthcare company GlaxoSmithKline (GSK), announced its decision to build a new ...
Cordis Corporation was established in Miami in Florida, US in 1959. The company is a subsidiary of the pharmaceutical major ...
Bidachem SPA is one of the major manufacturers of fine chemicals and active pharmaceutical ingredients (APIs) in Italy. The company ...
Signifor (SOM230 / Pasireotide) is a somatostatin analogue indicated for the treatment of patients with Cushing's disease for whom surgery ...
Under development by Amarin Corporation, AMR101 is a partially synthetic omega-3 fatty acid-based drug. It contains the purest form of ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.